1 Market Overview
1.1 mRNA Vaccines & Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Standardization Of Cancer Treatment MRNA Vaccine
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Applications
1.3.1 Infectious Disease
1.3.2 Cancer
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Business Overview
2.1.2 mRNA Vaccines & Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 CureVac
2.2.1 Business Overview
2.2.2 mRNA Vaccines & Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 Translate Bio
2.3.1 Business Overview
2.3.2 mRNA Vaccines & Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 BioNTech
2.4.1 Business Overview
2.4.2 mRNA Vaccines & Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 Sangamo Therapeutics
2.5.1 Business Overview
2.5.2 mRNA Vaccines & Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.6 Argos Therapeutics
2.6.1 Business Overview
2.6.2 mRNA Vaccines & Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.7 In-Cell-Art
2.7.1 Business Overview
2.7.2 mRNA Vaccines & Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.8 eTheRNA
2.8.1 Business Overview
2.8.2 mRNA Vaccines & Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.9 Ethris
2.9.1 Business Overview
2.9.2 mRNA Vaccines & Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.10 Tiba Biotechnology
2.10.1 Business Overview
2.10.2 mRNA Vaccines & Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global mRNA Vaccines & Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2017-2019)
3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global mRNA Vaccines & Therapeutics Market Analysis by Regions
4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2015-2019)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2015-2019)
4.2 North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
4.3 Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
4.5 South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
5 North America mRNA Vaccines & Therapeutics by Country
5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2019)
5.1.2 North America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2019)
5.2 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
5.3 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
5.4 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
6 Europe mRNA Vaccines & Therapeutics by Country
6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2019)
6.1.2 Europe mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2019)
6.2 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
6.3 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
6.4 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
6.5 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
6.6 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
7 Asia-Pacific mRNA Vaccines & Therapeutics by Country
7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2019)
7.2 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
7.3 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
7.4 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
7.5 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
7.6 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
8 South America mRNA Vaccines & Therapeutics by Country
8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2019)
8.1.2 South America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2019)
8.2 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
8.3 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
8.4 Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
9 Middle East and Africa mRNA Vaccines & Therapeutics by Countries
9.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
9.3 Turkey mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
9.4 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
9.5 Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
9.6 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2019)
10 Global mRNA Vaccines & Therapeutics Market Segment by Type
10.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2015-2019)
10.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2015-2019)
10.2 Standardization Of Cancer Treatment MRNA Vaccine Sales Growth and Price
10.2.1 Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2015-2019)
10.2.2 Global Standardization Of Cancer Treatment MRNA Vaccine Price (2015-2019)
10.3 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price
10.3.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2015-2019)
10.3.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2015-2019)
10.4 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price
10.4.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2015-2019)
10.4.2 Global Infectious Disease Treatment MRNA Vaccine Price (2015-2019)
10.5 Infection Prevention MRNA Vaccine Sales Growth and Price
10.5.1 Global Infection Prevention MRNA Vaccine Sales Growth (2015-2019)
10.5.2 Global Infection Prevention MRNA Vaccine Price (2015-2019)
11 Global mRNA Vaccines & Therapeutics Market Segment by Application
11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2019)
11.2 Infectious Disease Sales Growth (2015-2019)
11.3 Cancer Sales Growth (2015-2019)
11.4 Other Sales Growth (2015-2019)
12 mRNA Vaccines & Therapeutics Market Forecast (2020-2025)
12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2020-2025)
12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2020-2025)
12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2020-2025)
12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2020-2025)
12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2020-2025)
12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2020-2025)
12.2.5 Middle East and Africa mRNA Vaccines & Therapeutics Market Forecast (2020-2025)
12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2020-2025)
12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2020-2025)
12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2020-2025)
12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2020-2025)
12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2020-2025)
12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
